Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
BMJ Case Reports|January 14, 2018
Spontaneous splenic rupture as a rare complication of G-CSF injectionSoraya Benguerfi, Fanny Thepault, Hervé Lena, et al.
Translational Lung Cancer Research|March 26, 2015
How old is "too old" for translational research?Alain Vergnenegre, Romain Corre, Hervé Lena, et al.
Translational Lung Cancer Research|March 26, 2015
Management of elderly patientsAlain Vergnenegre, Romain Corre, Hervé Lena, et al.
Frontiers in Oncology|April 25, 2022
Preclinical Models for Acquired Resistance to Third-Generation EGFR Inhibitors in NSCLC: Functional Studies and Drug Combinations Used to Overcome ResistanceEmna Mahfoudhi, Charles Ricordel, Gwendoline Lecuyer, et al.
Chest|May 12, 2004
Survival of patients with bronchiectasis after the first ICU stay for respiratory failureMathieu Dupont, Arnaud Gacouin, Hervé Lena, et al.
Bulletin Du Cancer|April 12, 2026
[Metabolic and cardiovascular disorders with lorlatinib: How to detect and manage them in practice?]Jennifer Arrondeau, Stéphane Ederhy, Christophe Héron, et al.
Respiratory Medicine and Research|June 12, 2023
Treatment patterns and clinical outcomes of extensive stage small cell lung cancer (SCLC) in the real-world evidence ESME cohort before the era of immunotherapyClarisse Audigier Valette, Thomas Filleron, Didier Debieuvre, et al.
Bulletin Du Cancer|March 8, 2022
[Central nervous system disorders on lorlatinib: How to detect and manage in practice?]Vincent Fallet, Pascal Rouby, Guido Ahle, et al.
Experimental Lung Research|June 7, 2006
Increased extracellular matrix metalloproteinase inducer (EMMPRIN) expression in pulmonary fibrosisStéphanie Guillot, Philippe Delaval, Graziella Brinchault, et al.
Oncology and Therapy|May 3, 2026
Treatment Sequencing and Immunotherapy Rechallenge in Advanced Non-Small-Cell Lung Cancer: Final 24-Month Real-World Results from the French LIST StudyBenoît Godbert, Elisa Gobbini, Yaacoub Khalife, et al.
Pageof 4